Massachusetts Financial Services’s Palvella Therapeutics PVLA Stock Holding History

Massachusetts Financial Services’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$642K	Buy	4,198 +2,063	+97%	+$250K	﹤0.01%	933
2026 Q1	$266K	Buy	+2,135	New	+$223K	﹤0.01%	926
2020 Q2	–	Sell	-1,283	Closed	-$234K	–	853
2020 Q1	$234K	Buy	1,283 +203	+19%	+$51.2K	﹤0.01%	788
2019 Q4	$313K	Sell	1,080 -117	-10%	-$32.4K	﹤0.01%	798
2019 Q3	$327K	Buy	1,197 +134	+13%	+$51.9K	﹤0.01%	809
2019 Q2	$400K	Buy	1,063 +148	+16%	+$44.1K	﹤0.01%	822
2019 Q1	$245K	Buy	915 +34	+4%	+$8.08K	﹤0.01%	829
2018 Q4	$187K	Buy	881 +68	+8%	+$21.1K	﹤0.01%	843
2018 Q3	$364K	Buy	+813	New	+$353K	﹤0.01%	838

Other funds holding PVLA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

CAM

Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Massachusetts Financial Services's PVLA Position: Q2 2026 in Review

Massachusetts Financial Services increased its Palvella Therapeutics (PVLA) stake by 97% in Q2 2026, buying an estimated $250K and bringing the position to 4,198 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Massachusetts Financial Services first reported a position in PVLA in Q3 2018 and has held it in 9 quarters since. 63 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Massachusetts Financial Services held 4,198 shares of Palvella Therapeutics worth $642K as of Q2 2026.
Massachusetts Financial Services bought 2,063 Palvella Therapeutics shares in Q2 2026, an estimated $250K.
Palvella Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #933 holding.
Massachusetts Financial Services first reported a position in Palvella Therapeutics in Q3 2018 and has held it in 9 quarters since.
63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.